Nuveen Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$3.55M Sell
95,665
-112,307
-54% -$4.17M ﹤0.01% 2135
2024
Q3
$10.1M Sell
207,972
-93,617
-31% -$4.54M ﹤0.01% 1599
2024
Q2
$12.1M Buy
301,589
+114,098
+61% +$4.56M ﹤0.01% 1473
2024
Q1
$8.23M Sell
187,491
-2,356
-1% -$103K ﹤0.01% 1722
2023
Q4
$11.7M Sell
189,847
-164,112
-46% -$10.2M ﹤0.01% 1494
2023
Q3
$16.3M Sell
353,959
-20,560
-5% -$946K 0.01% 1163
2023
Q2
$21.5M Buy
374,519
+56,195
+18% +$3.23M 0.01% 1024
2023
Q1
$11.9M Sell
318,324
-65,681
-17% -$2.46M ﹤0.01% 1372
2022
Q4
$10.8M Sell
384,005
-32,602
-8% -$913K ﹤0.01% 1439
2022
Q3
$11.7M Sell
416,607
-174,217
-29% -$4.9M ﹤0.01% 1383
2022
Q2
$20.6M Buy
590,824
+114,149
+24% +$3.97M 0.01% 1031
2022
Q1
$16.9M Buy
476,675
+93,448
+24% +$3.31M 0.01% 1296
2021
Q4
$8.26M Buy
383,227
+9,175
+2% +$198K ﹤0.01% 1811
2021
Q3
$6.87M Sell
374,052
-45,085
-11% -$828K ﹤0.01% 2041
2021
Q2
$8.45M Buy
419,137
+243,749
+139% +$4.91M ﹤0.01% 1969
2021
Q1
$3.21M Sell
175,388
-11,172
-6% -$205K ﹤0.01% 2385
2020
Q4
$3.75M Sell
186,560
-18,626
-9% -$375K ﹤0.01% 2219
2020
Q3
$3.85M Buy
205,186
+20,651
+11% +$387K ﹤0.01% 2055
2020
Q2
$4.15M Buy
184,535
+46,580
+34% +$1.05M ﹤0.01% 2003
2020
Q1
$2.05M Sell
137,955
-390
-0.3% -$5.79K ﹤0.01% 2173
2019
Q4
$2.67M Sell
138,345
-165,026
-54% -$3.18M ﹤0.01% 2306
2019
Q3
$6.02M Sell
303,371
-271,412
-47% -$5.38M ﹤0.01% 1863
2019
Q2
$12.1M Buy
+574,783
New +$12.1M ﹤0.01% 1477